 GAVIN
|
Gador
|
| pregabalina |
Antiepiléptico |
| 150 mg cáps.x 28 | $46.668,31 | (30/08/24) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $22.656,90 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $27.903,21 AF $18.765,10 |
|
|
|
|
| 150 mg cáps.x 30 | $50.321,41 | (04/02/25) |
| PAMI |
|
| AF $23.215,26 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $27.989,52 AF $22.331,89 |
|
|
|
|
| 25 mg cáps.x 28 | $10.221,16 | (30/08/24) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $4.426,92 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $7.206,03 AF $3.015,13 |
|
|
|
|
| 25 mg cáps.x 30 | $10.793,18 | (04/02/25) |
| PAMI |
|
| AF $4.623,44 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $7.262,08 AF $3.531,10 |
|
|
|
|
| 300 mg cáps.x 28 | $64.223,31 | (16/07/24) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $31.222,39 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $42.426,32 AF $21.796,99 |
|
|
|
|
| 300 mg cáps.x 30 | $65.524,28 | (04/02/25) |
| PAMI |
|
| AF $31.377,10 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $41.488,21 AF $24.036,07 |
|
|
|
|
| 50 mg cáps.x 28 | $20.910,03 | (30/08/24) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $8.940,50 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $16.192,02 AF $4.718,01 |
|
|
|
|
| 50 mg cáps.x 30 | $23.295,15 | (04/02/25) |
| PAMI |
|
| AF $10.305,29 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $15.449,24 AF $7.845,91 |
|
|
|
|
| 75 mg cáps.x 28 | $27.048,93 | (16/07/24) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $13.524,47 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $18.452,49 AF $8.596,44 |
|
|
|
|
| 75 mg cáps.x 30 | $29.896,24 | (04/02/25) |
| PAMI |
|
| AF $14.291,20 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $19.932,47 AF $9.963,77 |
|
|
|
|
| |
